期刊文献+

ANGPTL2表达与急性冠脉综合征患者的关联性及其意义 被引量:1

Association and significance of ANGPTL2 and patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨血管生成素样蛋白(angiopoietinlike protein,ANGPTL)2表达与急性冠脉综合征(ACS)患者的关联性及其意义。方法冠心病患者121例分为2组:ACS组〔88例,其中ST段抬高型急性心肌梗死(STEMI)48例,非ST段抬高型急性冠脉综合征(NSTE-ACS)40例〕和稳定型心绞痛(SAP)组(33例)。收集外周血血浆,采用酶联免疫吸附试验检测ANGPTL2的浓度;抽吸获得STEMI患者的冠脉血栓,免疫组化SABC法检测ANGPTL2在冠脉血栓中的表达情况。结果 ANGPTL2血浆浓度在ACS组显著高于SAP组(P<0.01),并且在STEMI组也显著高于NSTE-ACS组(P<0.01)。多因素回归分析显示,ANGPTL2为ACS的独立相关因素(OR=3.15,95%CI,1.64-6.02,P<0.01)。ANGPTL2在STEMI患者的冠脉血栓中高表达。结论 ANGPTL2在ACS患者中高表达是ACS患者的独立相关因素,也可能与血小板成栓有密切关系。 AIM To investigate the significance and association of angiopoietin-like protein 2 (ANGPTL2) in acute coronary syndrome (ACS) patients. METHODS One hundred and twenty-one subjects were recruited and were divided into ACS group [ n = 88 patients, including 48 patients with ST-segment eleva- tion myocardial infarction (STEMI) and 40 patients with non-ST elevation acute coronary syndrome (NSTE-ACS) ] and stable angina pectoris (SAP) group (n = 33 ). Peripheral blood plasma was collected and enzyme-linked immunosorbent assay was used to test the concentration of ANGPTL2. Aspiration was used to obtain coronary thrombus in STEMI patients and ANGPTL2 expression was detected by SABC immunohistochemieal method. RESULTS Plasma ANGPTL2 levels in ACS patients were significantly higher than in SAP patients ( P 〈 0.01 ). Plasma ANGPTL2 levels in patients with STEMI were signifi- candy higher than those in patients with NSTE-ACS ( P 〈 0. 01 ). Multivariate analysis showed that ANGPTL2 was an independent risk factor of ACS. In addition, ANGPTL2 was highly expressed in coronary thrombus. CONCLUSION High expression of ANGPTL2 in ACS patients is an independently associated factor and may have a close relationship with platelet thrombus.
作者 郭玲玉 陈一竹 杨文龙 张明亮 周璇 许盛松 张俊峰 GUO Ling-yu CHEN Yi-zhu YANG Wen-long ZHANG Ming-liang ZHOU Xuan XU Sheng-song ZHANG Jun-feng(Department of Cardiology, Third People' s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201999, China)
出处 《心脏杂志》 CAS 2017年第1期52-54,59,共4页 Chinese Heart Journal
基金 上海市自然科学基金资助(16ZR1419900)
关键词 急性冠脉综合征 血管生成素样蛋白2 血小板 血栓 acute coronary syndrome angiopoietin-like protein 2 platelet thrombus
  • 相关文献

参考文献3

二级参考文献56

  • 1王小艳.急性冠脉综合征后6个月死亡和心肌梗死的预测:前瞻性的多国观察性研究(GRACE)[J].中国处方药,2006(11):25-26. 被引量:139
  • 2王小艳.早期强化他汀治疗对急性冠脉综合征的效果[J].中国处方药,2006(11):26-26. 被引量:8
  • 3Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 4Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 5Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 6Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 7O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 8Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 9Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 10Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.

共引文献2863

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部